FDA
approval
· 2015-02-18
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
FDA approved a supplemental application for the Irbesartan and Hydrochlorothiazide fixed-dose combination from Macleods Pharmaceuticals Limited, used to treat h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)